Literature DB >> 22957409

Cancer quackery: the persistent popularity of useless, irrational 'alternative' treatments.

Barrie R Cassileth1, Ian R Yarett.   

Abstract

At a time when many readily believe that vaccines cause autism, or that government scientists created AIDS as a weapon of black genocide, it is not surprising that medical quackery, especially cancer quackery, remains a flourishing and lucrative business throughout the developed world. This review provides a brief recap of its history and an overview of the various types of unproven or disproved cancer therapies popular now in the United States and elsewhere.

Entities:  

Mesh:

Year:  2012        PMID: 22957409

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  6 in total

1.  Integrative oncology: really the best of both worlds?

Authors:  David H Gorski
Journal:  Nat Rev Cancer       Date:  2014-10       Impact factor: 60.716

2.  Exploring an herbal "wonder cure" for cancer: a multidisciplinary approach.

Authors:  Eran Ben-Arye; Jamal Mahajna; Radi Aly; Mohammed Saleem Ali-Shtayeh; Yedidia Bentur; Efraim Lev; Gary Deng; Noah Samuels
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-07       Impact factor: 4.553

Review 3.  Influence of Internet and Social Media in the Promotion of Alternative Oncology, Cancer Quackery, and the Predatory Publishing Phenomenon.

Authors:  Pedro David Delgado-López; Eva María Corrales-García
Journal:  Cureus       Date:  2018-05-13

4.  Toxicity of colloidal silver products and their marketing claims in Finland.

Authors:  Veera Leino; Riikka Airaksinen; Matti Viluksela; Kirsi Vähäkangas
Journal:  Toxicol Rep       Date:  2020-12-26

Review 5.  Medical Gas Therapy for Tissue, Organ, and CNS Protection: A Systematic Review of Effects, Mechanisms, and Challenges.

Authors:  Ross D Zafonte; Lei Wang; Christian A Arbelaez; Rachel Dennison; Yang D Teng
Journal:  Adv Sci (Weinh)       Date:  2022-03-04       Impact factor: 17.521

6.  Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2.

Authors:  Meng Li; Huashan Shi; Yandong Mu; Zichao Luo; Hailong Zhang; Yang Wan; Dongmei Zhang; Lian Lu; Ke Men; Yaomei Tian; Xiaozhe Wu; Xiaoyan Liu; Ying Pan; Yingzi Fan; Chaoheng Yu; Bailing Zhou; Rong Xiang; Xiancheng Chen; Li Yang
Journal:  Mol Cancer       Date:  2014-07-28       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.